Coronavirus Notebook: EMA Says ‘Wait And See’ On CureVac Data, EU Ministers Want Voluntary Approach To Sharing IP

 
• By Ian Schofield

AstraZeneca and the European Commission have both claimed victory in the Vaxzevria supply case brought against the company by the commission. The Moderna coronavirus vaccine is now under review by the European Medicines Agency for use in younger people.

Close-up view of searching information on COVID 19 vaccine on the internet
The EMA gave an update on COVID-19 vaccines and medicines at its latest briefing • Source: Alamy

More from Europe

More from Geography